Two symptoms can accurately identify post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome.
Davenport, Todd E, Chu, Lily, Stevens, Staci R et al. · Work (Reading, Mass.) · 2023 · DOI
Quick Summary
This study found that asking patients about just two specific symptoms can accurately identify post-exertional malaise (PEM), the key feature of ME/CFS. Researchers had people with ME/CFS and healthy controls exercise twice, 24 hours apart, and report their symptoms at different times. The most reliable symptoms for identifying PEM were cognitive problems (brain fog), worsening function, and loss of positive feelings or mood.
Why It Matters
PEM is difficult to diagnose because it manifests in many different ways. This study provides clinicians with a quick, accurate screening tool using just two symptoms, potentially improving early identification and diagnosis of ME/CFS. Having a simple diagnostic marker could accelerate both clinical recognition and research enrollment.
Observed Findings
- Two symptom types were optimal to differentiate ME/CFS from healthy controls at most timepoints following exercise.
- Only one symptom was necessary to differentiate groups at one week following the second exercise test.
- Fatigue, cognitive dysfunction, lack of positive feelings/mood, and decreased function were consistent predictors of ME/CFS status across multiple timepoints.
- Postexertional cognitive dysfunction, functional decline, and anhedonia emerged as the most reliable symptom indicators.
Inferred Conclusions
- A brief two-symptom screen focusing on cognitive dysfunction, functional decline, and mood changes can efficiently identify PEM in clinical settings.
- Postexertional cognitive dysfunction may be a particularly sensitive marker for distinguishing ME/CFS from other fatigue conditions.
- Simplifying PEM assessment to just 1-2 key symptoms could improve accessibility and speed of diagnosis.
Remaining Questions
- Does this two-symptom screening tool perform equally well in diverse populations (different ages, disease severity, demographic groups)?
- How do these findings apply to patients with mild or severe ME/CFS, or those early in illness progression?
- Can this screening tool distinguish ME/CFS from other conditions that produce post-exertional fatigue, such as Long COVID or other post-viral syndromes?
- What is the optimal threshold for severity or duration of these two symptoms for clinical decision-making?
What This Study Does Not Prove
This study does not establish causation or explain the biological mechanisms underlying PEM. The small sample size (49 ME/CFS patients) limits generalizability, and the findings need validation in independent, larger populations before they can be reliably applied in routine clinical practice. This was a controlled laboratory setting and may not reflect how PEM manifests in real-world conditions.
Topics
Tags
Metadata
- DOI
- 10.3233/WOR-220554
- PMID
- 36938769
- Review status
- Editor reviewed
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 7 April 2026